Viewing Study NCT01433458


Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-02-22 @ 5:08 PM
Study NCT ID: NCT01433458
Status: COMPLETED
Last Update Posted: 2020-12-21
First Post: 2011-08-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module